Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02293070 · ClinicalTrials.gov registry record · NA

One More Magnetic Resonance Imaging

A NA study of Atrial Fibrillation, sponsored by Saint Luke's Health System.

Completed
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT02293070 is a NA study of Atrial Fibrillation that has completed, run by Saint Luke's Health System. The registered enrollment target is 32 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02293070, a NA study of Atrial Fibrillation, has completed, sponsored by Saint Luke's Health System.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to utilize delayed enhanced cardiac magnetic resonance imaging to assess the success of pulmonary vein isolation after cryoablation of paroxysmal atrial fibrillation. The primary hypothesis is that cardiac magnetic resonance imaging will be able to visualize changes in left atrial tissue characteristics caused by cryoablation used to treat paroxysmal atrial fibrillation.

Conditions Studied

Interventions

  • PROCEDURE Cryoablation
  • OTHER Delayed Enhanced Cardiac Magnetic Resonance Imaging

Study Locations (1)

Missouri

  • Saint Luke's Hospital - Kansas City

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2013-12
Est. Completion 2017-01
Phase NA

Sponsor

Saint Luke's Health System

26 total trials

What the Registry Record Tells You About NCT02293070

The ClinicalTrials.gov registry entry for NCT02293070 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (99% lower). The listed sponsor is Saint Luke's Health System, which has 26 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which Cryoablation is the first listed.

NCT02293070 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT02293070 about?

NCT02293070 is a clinical study titled "One More Magnetic Resonance Imaging". The objective of this study is to utilize delayed enhanced cardiac magnetic resonance imaging to assess the success of pulmonary vein isolation after cryoablation of paroxysmal atrial fibrillation. The primary hypothesis is that cardiac magnetic resonance imaging will be able to visualize changes in...

What is the current status of trial NCT02293070?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2013-12. Estimated completion is 2017-01.

What conditions does trial NCT02293070 study?

This clinical trial studies the following conditions: Atrial Fibrillation.

What interventions are being tested in trial NCT02293070?

The interventions under investigation include: Cryoablation (PROCEDURE), Delayed Enhanced Cardiac Magnetic Resonance Imaging (OTHER).

Who is sponsoring clinical trial NCT02293070?

This trial is sponsored by Saint Luke's Health System, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02293070 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.